Analysts think RCEL stock price could increase by 86%
Sep 12, 2025, 11:26 AM
54.91%
What does RCEL do
AVITA Medical, headquartered in Valencia, California, specializes in point-of-care autologous skin restoration using its RECELL platform for treating burn injuries and skin defects. The company went public on March 18, 2012, and employs 207 people.
7 analysts think RCEL stock price will increase by 86.30%. The current median analyst target is $8.16 compared to a current stock price of $4.38. The lowest analysts target is $3.03 and the highest analyst target is $18.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.